Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.5B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Tesla
TSLA
|
+$951M |
| 4 |
Johnson & Johnson
JNJ
|
+$750M |
| 5 |
UnitedHealth
UNH
|
+$703M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$913M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$257M |
| 3 |
NVIDIA
NVDA
|
+$225M |
| 4 |
Vertiv
VRT
|
+$164M |
| 5 |
JPMorgan Chase
JPM
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.48% |
| 2 | Healthcare | 7.36% |
| 3 | Financials | 6.5% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
YMAB
4401
DELISTED
Y-mAbs Therapeutics
YMAB
| $48.1K | ﹤0.01% |
9,859
-54,586
| -85% | -$397K |
|
4402
Turkcell
TKC
$4.68B
| $47.9K | ﹤0.01% |
+10,000
| New | +$39.2K |
|
|
ICVX
4403
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $47.8K | ﹤0.01% |
6,020
+5,026
| +506% | +$21.6K |
|
4404
Acrivon Therapeutics
ACRV
$64.2M
| $47.7K | ﹤0.01% |
+4,142
| New | +$52.6K |
|
4405
Ivanhoe Electric
IE
$1.45B
| $47.3K | ﹤0.01% |
3,896
+3,281
| +533% | +$34.4K |
|
|
GPGI
4406
GPGI Inc
GPGI
$3.83B
| $47.3K | ﹤0.01% |
11,605
+10,618
| +1,076% | +$44.1K |
|
4407
908 Devices
MASS
$329M
| $47.1K | ﹤0.01% |
6,186
+5,259
| +567% | +$63.6K |
|
4408
CALL
Labcorp
LH
$25B
| $47.1K | ﹤0.01% |
+233
| New | +$45.5K |
|
4409
Sensus Healthcare
SRTS
$47.9M
| $46.9K | ﹤0.01% |
6,319
+5,547
| +719% | +$50K |
|
4410
Kodak
KODK
$822M
| $46.8K | ﹤0.01% |
15,348
+12,925
| +533% | +$56.8K |
|
4411
iShares Global Energy ETF
IXC
$2.79B
| $46.8K | ﹤0.01% |
1,200
-3,720
| -76% | -$146K |
|
4412
Assembly Biosciences
ASMB
$498M
| $46.7K | ﹤0.01% |
2,994
-106
| -3% | -$1.81K |
|
4413
Ranger Energy Services
RNGR
$376M
| $46.7K | ﹤0.01% |
4,239
+3,514
| +485% | +$37.1K |
|
|
MOND
4414
DELISTED
Mondee Holdings, Inc. Class A Common Stock
MOND
| $46.6K | ﹤0.01% |
4,286
| – | – |
|
|
HEPS
4415
D-Market Electronic Services & Trading
HEPS
$1.05B
| $46.2K | ﹤0.01% |
70,000
| – | – |
|
|
PAMT
4416
PAMT Corp
PAMT
$337M
| $45.8K | ﹤0.01% |
1,770
+1,442
| +440% | +$41.1K |
|
4417
RGC Resources
RGCO
$223M
| $45.7K | ﹤0.01% |
2,071
+1,126
| +119% | +$25K |
|
4418
TFS Financial
TFSL
$5.16B
| $45.5K | ﹤0.01% |
3,159
-1,263
| -29% | -$17.3K |
|
4419
Cato Corp
CATO
$68.3M
| $45.4K | ﹤0.01% |
4,867
+589
| +14% | +$6.03K |
|
|
VLTA
4420
DELISTED
Volta Inc.
VLTA
| $45K | ﹤0.01% |
126,555
+28,074
| +29% | +$21.3K |
|
|
ALPN
4421
DELISTED
Alpine Immune Sciences Inc
ALPN
| $44.7K | ﹤0.01% |
6,080
+5,418
| +818% | +$34.6K |
|
4422
Legacy Housing
LEGH
$625M
| $44.5K | ﹤0.01% |
2,349
+1,705
| +265% | +$30K |
|
4423
Veritone
VERI
$101M
| $44.5K | ﹤0.01% |
8,400
+7,074
| +533% | +$45.4K |
|
|
KALV
4424
DELISTED
KalVista Pharmaceuticals
KALV
| $44.4K | ﹤0.01% |
6,572
+3,923
| +148% | +$21K |
|
4425
BRC Inc
BRCC
$121M
| $44.3K | ﹤0.01% |
7,258
+6,153
| +557% | +$40.2K |
|
Similar funds
Barclays's Q4 2022 Portfolio in Review
As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $128B of net new capital in Q4 2022, opening 798 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.
- Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
- Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
- Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
- Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
- Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
- Barclays opened 798 new positions and closed 385 in Q4 2022.
- Barclays's portfolio value rose 144% quarter-over-quarter to $223B.
Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.